George Pavlakis

Citado por

	Total	Desde 2020
Citas	30414	5816
Índice h	91	34
Índice i10	279	132

1400

700

350

1050

1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025103 141 196 226 350 494 534 457 674 653 675 725 755 735 717 705 640 747 777 732 804 850 871 879 942 940 930 1068 1041 965 920 917 938 970 1024 1230 1302 1139 1009 103

Acceso público

Ver todo

116 artículos

7 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Rashmi JalahWalter Reed Army Institute of Research (WRAIR)Dirección de correo verificada de hivresearch.org
Bette KorberLos Alamos National LaboratoryDirección de correo verificada de lanl.gov
Tomoshige KinoSidra Medical and Research CenterDirección de correo verificada de sidra.org
George P. ChrousosProfessor, School of Medicine, National and Kapodistrian University of AthensDirección de correo verificada de med.uoa.gr
GragerovOmeros CorporationDirección de correo verificada de omeros.com
Beatriz Mothe, MD, PhD. Associate Inv...Infectious Diseases Department & IrsiCaixa AIDS Research Institute; Hospital Universitari GermansDirección de correo verificada de irsicaixa.es
Michele A. Wetzel KutzlerDrexel University College of MedicineDirección de correo verificada de drexelmed.edu
Morgane RollandMHRP|HJFDirección de correo verificada de hivresearch.org
Eva Maria FenyöProfessor of Virology, Lund UniversityDirección de correo verificada de med.lu.se
brunda ganneruSenior Scientist, R&D, Bharat Biotech International LimitedDirección de correo verificada de iitr.res.in
Mario RoedererVaccine Research Center, NIAID, NIHDirección de correo verificada de nih.gov
Shari N GordonGlaxoSmithKline and the UNC HIV Cure CenterDirección de correo verificada de gsk.com
Carlos TaberneroLecturer on History of Science, Autonomous University of BarcelonaDirección de correo verificada de uab.cat
Rama AmaraCharles Howard Candler Professor of Microbiology and Immunology, Emory UniversityDirección de correo verificada de emory.edu
Leondios KostrikisProfessor of Biological Sciences, University of CyprusDirección de correo verificada de ucy.ac.cy
Jeffrey KoppNIDDK, NIHDirección de correo verificada de nih.gov
David HeckermanMicrosoft ResearchDirección de correo verificada de microsoft.com
Jacek SkowronskiCase Western Reserve School of MedicineDirección de correo verificada de case.edu
Michael E GreenbergDirección de correo verificada de hms.harvard.edu
Iacob MathiesenOtivio ASDirección de correo verificada de otivio.com

Seguir

George Pavlakis

National Cancer Institute

Dirección de correo verificada de ncifcrf.gov

Biology


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Automatic and quantitative measurement of protein-protein colocalization in live cells SV Costes, D Daelemans, EH Cho, Z Dobbin, G Pavlakis, S Lockett Biophysical journal 86 (6), 3993-4003, 2004	1634	2004
Improved DNA: liposome complexes for increased systemic delivery and gene expression NS Templeton, DD Lasic, PM Frederik, HH Strey, DD Roberts, ... Nature biotechnology 15 (7), 647-652, 1997	970	1997
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. BK Felber, M Hadzopoulou-Cladaras, C Cladaras, T Copeland, ... Proceedings of the National Academy of Sciences 86 (5), 1495-1499, 1989	891	1989
Human retroviruses and AIDS G Myers, B Korber, S Wain-Hobson, RF Smith, GN Pavlakis Los Alamos National Laboratory, Los Alamos, N. Mex, 1993	764	1993
Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences G Myers, B Korber, S Wain-Hobson, RF Smith, GN Pavlakis Los Alamos National Laboratory, Los Alamos, N. Mex, 1995	715*	1995
The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats BK Felber, H Paskalis, C Kleinman-Ewing, F Wong-Staal, GN Pavlakis Science 229 (4714), 675-679, 1985	623	1985
Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 S Schwartz, BK Felber, DM Benko, EM Fenyö, GN Pavlakis Journal of virology 64 (6), 2519-2529, 1990	583	1990
The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region M Hadzopoulou-Cladaras, BK Felber, C Cladaras, A Athanassopoulos, ... Journal of virology 63 (3), 1265-1274, 1989	443	1989
Human retroviruses and AIDS, 1992 G Myers, B Korber, JA Berzofsky, GN Pavlakis, RF Smith Los Alamos National Lab., NM (United States), 1992	400	1992
Labeling extracellular vesicles for nanoscale flow cytometry A Morales-Kastresana, B Telford, TA Musich, K McKinnon, C Clayborne, ... Scientific reports 7 (1), 1878, 2017	380	2017
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications IP Trougakos, K Stamatelopoulos, E Terpos, OE Tsitsilonis, E Aivalioti, ... Journal of Biomedical Science 28, 1-18, 2021	371	2021
Efficient production and enhanced tumor delivery of engineered extracellular vesicles DC Watson, D Bayik, A Srivatsan, C Bergamaschi, A Valentin, G Niu, ... Biomaterials 105, 195-205, 2016	370	2016
Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs S Schwartz, BK Felber, EM Fenyö, GN Pavlakis Journal of virology 64 (11), 5448-5456, 1990	360	1990
Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression S Schwartz, M Campbell, G Nasioulas, J Harrison, BK Felber, ... Journal of virology 66 (12), 7176-7182, 1992	355	1992
Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation R Schneider, M Campbell, G Nasioulas, BK Felber, GN Pavlakis Journal of virology 71 (7), 4892-4903, 1997	349	1997
Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein S Schwartz, BK Felber, GN Pavlakis Journal of virology 66 (1), 150-159, 1992	346	1992
The structural basis for spectral variations in green fluorescent protein GJ Palm, A Zdanov, GA Gaitanaris, R Stauber, GN Pavlakis, A Wlodawer Nature structural biology 4 (5), 361-365, 1997	330	1997
High-content screening: a new approach to easing key bottlenecks in the drug discovery process KA Giuliano, RL DeBiasio, RT Dunlay, A Gough, JM Volosky, J Zock, ... SLAS Discovery 2 (4), 249-259, 1997	317	1997
Expression and characterization of the trans-activator of HTLV-III/LAV virus CM Wright, BK Felber, H Paskalis, GN Pavlakis Science 234 (4779), 988-992, 1986	314	1986
Co‐localization of HIV‐1 Nef with the AP‐2 adaptor protein complex correlates with Nef‐induced CD4 down‐regulation ME Greenberg, S Bronson, M Lock, M Neumann, GN Pavlakis, ... The EMBO journal, 1997	306	1997

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores